Butler E G, Eckerson H W, La Du B N
Drug Metab Dispos. 1985 Nov-Dec;13(6):640-5.
Hydrolysis and covalent binding to nonessential esterases are two biochemical processes which can prevent paraoxon from reacting with the essential enzyme, acetylcholinesterase. Both processes have been proposed as the primary route of paraoxon detoxification in vivo. These experiments were designed to assess the relative contribution of each pathway to the disappearance of paraoxon in the rabbit. In vitro, paraoxon disappeared from whole rabbit blood with a t 1/2 of 17.7 sec. Hydrolysis by paraoxonase (EC 3.1.1.2) accounted entirely for this disappearance and covalent binding contributed essentially nothing. In vivo, following an iv injection of 0.15 mg/kg paraoxon, serum paraoxonase hydrolyzed as much as 41% of the injected dose within the first 30 sec. Pretreatment of rabbits with an ip injection of tri-o-tolyl phosphate eliminated more than 95% of the paraoxon binding sites. However, pretreatment with tri-o-tolyl phosphate had no significant effect on the t 1/2 or volume of distribution of paraoxon, indicating that covalent binding sites did not contribute significantly to the clearance of paraoxon from whole rabbits under these conditions. Hydrolysis of paraoxon by tissue paraoxonases, in addition to that catalyzed by paraoxonase in the blood, could account for its rapid metabolism. These findings demonstrate that paraoxonase has a major role in the disappearance of paraoxon in the rabbit. This suggests that susceptibility of people to chronic paraoxon poisoning may vary, according to their inherited level and type of serum paraoxonase.
水解以及与非必需酯酶的共价结合是两个生化过程,它们能够阻止对氧磷与关键酶乙酰胆碱酯酶发生反应。这两个过程均被认为是对氧磷在体内解毒的主要途径。设计这些实验旨在评估每条途径对家兔体内对氧磷消失的相对贡献。在体外,对氧磷从家兔全血中消失的半衰期为17.7秒。对氧磷酶(EC 3.1.1.2)催化的水解完全导致了这种消失,而共价结合基本没有作用。在体内,静脉注射0.15毫克/千克对氧磷后,血清对氧磷酶在最初30秒内水解了高达41%的注射剂量。腹腔注射磷酸三邻甲苯酯对家兔进行预处理可消除超过95%的对氧磷结合位点。然而,用磷酸三邻甲苯酯进行预处理对对氧磷的半衰期或分布容积没有显著影响,这表明在这些条件下,共价结合位点对对氧磷从整个家兔体内的清除没有显著贡献。除了血液中的对氧磷酶催化的水解外,组织对氧磷酶对氧磷的水解也可能是其快速代谢的原因。这些发现表明,对氧磷酶在对氧磷在家兔体内的消失过程中起主要作用。这表明,根据个体遗传的血清对氧磷酶水平和类型,人们对慢性对氧磷中毒的易感性可能会有所不同。